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The  interaction  between  IgE antibodies  and  allergens  is  a key  event  in  triggering  an  allergic  reaction.  The
characterization  of  this  region  provides  information  of  paramount  importance  for diagnosis  and  therapy.
Par j 2 Lipid  Transfer  Protein  is  one  of  the  most important  allergens  in  southern  Europe  and  a well-
established  marker  of  sensitization  in  Parietaria  pollen  allergy.  The  main  aim  of  this study  was  to  map  the
IgE  binding  regions  of this  allergen  and  to study  the  pattern  of  reactivity  of  individual  Parietaria-allergic
patients.  By  means  of  gene  fragmentation,  six  overlapping  peptides  were  expressed  in Escherichia  coli,  and
their IgE  binding  activity  was evaluated  by  immunoblotting  in  a cohort  of  79 Parietaria-allergic  patients.arietaria
gE
pitope mapping
olecular biology
Our  results  showed  that Pj-allergic  patients  display  a heterogeneous  pattern  of  IgE  binding  to  the  different
recombinant  fragments,  and  that  patients  reacted  simultaneously  against  several  protein  domains  spread
all the  over  the  molecule,  even  in  fragments  which  do not  contain  structural  features  resembling  the
native  allergen.  Our  results  reveal  the  presence  of a large  number  of  linear  and  conformational  epitopes
on  the  Par  j  2 sequence,  which  probably  explains  the high  allergenic  activity of this  allergen.. Introduction
An allergic reaction is initiated by a series of cellular events
hich are primarily mediated by the interaction between IgE anti-
odies and allergens. The major event is the cross-linking of IgE on
ast cells and basophils, leading to the release of the inﬂamma-
ory mediators responsible for the immediate reaction, but other
mmunological mechanisms involving IgE antibodies have also
een described (Acharya et al., 2010; van der Heijden et al., 1993;
ing et al., 2001). However, despite the pivotal role established
or IgE in allergic reactions, little is known about the interaction
etween allergens and antibodies, mainly due to the low concen-
ration of this class of immunoglobulin in the sera of patients and to
he fact that IgE-producing B cells have been poorly characterized
reviewed by (Gadermaier et al., 2014)]. Most of the data related
o this aspect are derived from in vitro assays using mouse mono-
lonal antibodies and/or recombinant chimeric human IgE derived
rom mouse antibodies (Tai et al., 2013; Tiwari et al., 2012). In this
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respect, it has been demonstrated that human allergen-speciﬁc IgE
may  interact in a different way  from mouse antibodies (Aalberse
and Crameri, 2011); therefore, these strategies may  not be able
to fully elucidate the overall spectrum of antibody recognition. In
addition, starting from the observation that the degree of effector
cell degranulation is determined by IgE concentration and the num-
ber of recognized epitopes (Gieras et al., 2007), this information can
be relevant for any strategy targeting IgE/allergen recognition.
In this context, little is known about the Lipid Transfer Protein
(LTP) family of allergens. LTPs are one of the more relevant classes
of allergenic proteins in pollen and plant-derived food (Campana
et al., 2011). These allergens are characterized by heat resistance
and stability at acidic pH as a consequence of their compact, highly
conserved three-dimensional structure, characterized by the pres-
ence of a conserved pattern of cysteine residues that forms four
disulphide bonds compacting four alpha-helices. This overall fold
has been detected in all the available structures of allergens belong-
ing to this family (Pfam database PF00234). These features make
this family of allergens of particular clinical interest since recent
studies have shown that, in food-allergic patients, the majority of
anaphylactic episodes occur in patients sensitized to LTPs (Asero
et al., 2009).
Parietaria judaica (Pj) pollen is one of the major outdoor aller-
genic sources in the Mediterranean area, with two major allergens
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FK1A  as a template. Panel B: Mapping of the predicted -helices and loops on the 
hich both belong to the LTP family (Par j 1 and Par j 2) (Colombo
t al., 2003). In particular, the Par j 2 allergen has been recog-
ized as the specie-speciﬁc allergen marker of Pj sensitization
Stumvoll et al., 2003) whose 3D model and disulphide bond assign-
ent has been determined (Amoresano et al., 2003; Colombo et al.,
998). Some preliminary studies have been performed attempting
o deﬁne B cell epitopes on both the Par j 1 and Par j 2 allergens
Asturias et al., 2003; Colombo et al., 1998; Costa et al., 2000).
In this study, we analyzed the IgE binding activity of six over-
apping regions of the Par j 2 allergen by using a set of 79 sera from
arietaria-allergic patients. This study allowed us to deﬁne a large
et of IgE binding epitopes on a relatively small allergenic protein
uch as the Par j 2, which can explain the high allergenic potency of
his protein and open the way to a rational approach for the design
f hypoallergenic derivatives for the members of this family.
. Materials and methods
.1. Study population
Between November 2005 and May  2006, 2150 children (10–17
ears old) living in Palermo, in the Mediterranean area of southern
taly, completed a questionnaire based on SIDRIA and ISAAC sur-
eys and underwent skin prick tests (SPT) at school (Cibella et al.,
011). Skin prick tests were performed according to EAACI rec-
mmendations, with a standard panel including Dermatophagoides
ix, grass mix, P. judaica, olive, dog and cat dander, alternaria, and
lattella germanica,  plus a positive (histamine 1%) and a negative
saline) control (Stallergènes Italia S.r.l., Milan, Italy). The reading
as performed after 15 min: reactions were considered positive if
he mean wheal diameter (computed as the maximum diameter
lus its orthogonal divided by 2) was 3 mm or greater, after having
ubtracted the wheal diameter of the reaction to the negative con-
rol. Allergic sensitization was deﬁned as the presence of at least
ne positive skin prick test. For the purpose of the present study, alltermined by using the Swiss-Model Protein Modelling Server using the PDB entry
 sequence.
the 311 children showing allergic sensitization for P. judaica were
recalled for further investigation. The study was  approved by the
Institutional Ethics Committee. All parents of invited adolescents
signed a written informed consent form. According to Italian law,
the respect of individual privacy was  guaranteed.
Of these, 79 children (mean age 15.7 years ± 0.9; 50 males) gave
their consent and, on the day of the study, each subject underwent
a new skin prick test and blood sampling. Sera were tested for the
presence of Par j 2 speciﬁc antibodies by means of Western blot. A
non-allergic subject was enrolled as a negative control.
2.2. In silico analysis
3D modelling was  performed using the SWISS MODEL
Workspace (http://swissmodel.expasy.org/workspace) and the
Predict Protein software (https://www.predictprotein.org). Puta-
tive antigenic determinants were analyzed by the ElliPro
Prediction software (http://tools.immuneepitope.org/tools/ElliPro/
iedb input). Based on the 3D structure of a protein antigen, ElliPro
predicts linear and discontinuous antibody epitopes by homology
modelling. ElliPro associates each predicted epitope with a score,
deﬁned as a PI (Protrusion Index) value, averaged over epitope
residues. For each residue, a PI value is deﬁned as percentage of
the protein atoms enclosed in the ellipsoid, which approximates
the protein surface, at which the residue ﬁrst comes to lie out-
side the ellipsoid; for example, all residues that are outside the
90% ellipsoid will have PI = 9 (or 0.9 in ElliPro). Prediction was per-
formed using the 1FK1A PDB entry. Peptide similarity was  studied
using the Structural Database of Allergenic Proteins (SDAP) soft-
ware (https://fermi.utmb.edu/).2.3. Gene fragmentation and recombinant protein expression
Different clones were obtained by PCR ampliﬁcation of
the Par j2.0101 template (accession number X95865). The
414 V. Longo et al. / Molecular Immunology 63 (2015) 412–419
F pes o
t pe. Pa
P
o
a
n
w
c
P
m
p
3
c
5
P
m
i
n
e
a
B
7
a
c
a
Cig. 2. In silico epitope prediction. Panel A: Predicted linear and discontinuous epito
he  predicted antibody binding. Score is the Protrusion Index of the predicted epito
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ligonucleotides were ﬂanked by the restriction enzyme EcoRI
nd XbaI recognition sites, plus 3 nucleotides for best recog-
ition of the restriction sites. The oligos used for cloning
ere: Parj2/for 5′ cgcGAATTCatgccgtgcctgcatttc 3′; Parj/2rev 5′
gcTCTAGActaatagtaacctctgaa 3′ (forward primer wild type Pa r j 2);
arj2/30 5′ cgcTCTAGAtgcagcactccttcgacgg 3′ (reverse primer frag-
ent A); Parj2/54 5′ cgcTCTAGAgcactatgcacttgcaggcctc 3′ (reverse
rimer fragment B); Parj2/37 5′ cgcGAATTCgcggcacgaagaagctgagc
′ (forward primer fragment C); Parj2/48 5′ cgcGAATTCaga-
gacggagcagaagagg 3′ (forward primer fragment D); Parj2/60
′ cgcGAATTCacgaagggcatctccg 3′ (forward primer fragment E);
arj2/76 5′ cgcTCTAGActtaatatcgcacttcttgg 3′ (reverse primer frag-
ents C–D). (Upper case indicates the restriction enzyme sites
ntroduced for cloning in the expression vector; italics indicate
ucleotides introduced for improving restriction enzyme cutting
fﬁciency; lower case indicates the Par j 2 coding regions.)
The fragments generated by PCR for subcloning mapped from
mino acid 1 to 30 (fragment A); from amino acid 1 to 54 (fragment
); from amino acid 37 to 76 (fragment C); from amino acid 48 to
6 (fragment D); from amino acid 60 to 76 (fragment E) and from
mino acid 60 to 102 (fragment F). Fragment A expresses a peptide
ontaining the loop 1 region (from aa 20 to 26); Fragment B loops 1
nd 2 (from aa 20 to 26 and from 42 to 46, respectively), Fragment
 loops 2 and 3 (from aa 41 to 48 and from 58 to 65, respectively);f the Par j 2 sequence. Numbers indicate the position of the amino acids involved in
nel B: Schematic representation of the predicted epitopes on the 3D model of the
Fragment D loop 3 (from aa 58 to 65); Fragment E a portion of loop
3 (from aa 60 to 65); Fragment F a portion of loop 3 and all of loop
4 (from aa 60 to 65 and from 73 to 87, respectively).
PCR products were puriﬁed, digested with EcoRI and XbaI
restriction enzymes, and cloned in frame in the EcoRI-XbaI sites
of the pMALC2 vector (BioLabs, UK). All the clones were sequenced
to check the open reading frame.
The recombinant clones were grown at 37 ◦C to a density of
0.5 ± 0.6 OD600 in LB broth with the appropriate antibiotic and
induced for 2 h with 0.3 mM isopropylthio--d-galactoside (IPTG).
The cells were harvested by centrifugation at 4000 × g for 20 min,
and the pellet was  then dissolved in 1× PBS (10 mM sodium phos-
phate, pH 7.2, 200 mM NaCl, 1 mM EDTA, and 1 mM NaN3) and
lysed by sonication with the Heat System Ultrasonic, W-385. Cell
debris was  removed by centrifugation at 9000 × g for 30 min. Super-
natants were collected and analyzed by SDS-PAGE and Coomassie
blue staining. A similar procedure was performed with a non-
recombinant empty pMAL-C2 vector to yield Escherichia coli total
extract for negative controls (pMAL lysate control).2.4. Immunoblot analysis
Twenty g of total E. coli protein cell lysate from recombi-
nant clones were fractionated on 16% SDS-PAGE and electroblotted
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ﬁig. 3. Schematic representation of w.t. Par j 2 and engineered peptides. Numbers
how  the putative disulphide bonds in the w.t. sequence (rPar j 2) and in the six reco
nto PVDF membranes (Immobilon P Millipore, USA). After blot-
ing, membranes were incubated for 1 h with blocking buffer (PBS
upplemented with 3% BSA, 0.5% Tween-20, and 0.02% NaN3) and
ashed three times with PBS containing 0.1% Tween-20. The ﬁlters
ere then incubated overnight with the single sera (1:5 dilu-
ion). A non-allergic serum was used as negative control. After
ashing, the ﬁlters were incubated for 1 h with horseradish per-
xidase HRP-conjugated rabbit antihuman IgE (1:5000 dilution)
Biosource International, USA). IgE reactive bands were visualized
y using SuperSignal West Pico Maximum Sensitivity Substrate
Pierce Biotechnology Inc, Rockford, USA) and subsequent exposure
o Kodak X-OMAT X-ray ﬁlm (Kodak, New York, NY). The inten-
ity of the Par j 2 signals was evaluated using a reference serum
++++ ≥60 kU/L; +++ ≥35 kU/L; ++ ≥10 kU/L and +≤10 kU/L) and
ensitometric analysis (Quantity ONE Software, Biorad, USA).
.5. Statistical analysis
Kendall Rank Correlation was used for evaluating the correlation
etween not normally distributed variables.
. Results
.1. In silico epitope prediction
In silico structural analysis of Par j 2 performed using the 1FK1A
DB structure as a model showed a canonical –––– LTP
tructure (Fig. 1, panel A). The predicted position of -helices and
oops are indicated in panel B of Fig. 1. For the prediction of puta-
ive IgE binding regions within the Par j 2 allergen, the full-length
equence was scanned using the Ellipro tool. The software identi-
ed four predicted regions of putative linear epitopes mapping theate the size of the peptides and the position of the cysteine residues. Dotted lines
ant derivatives. Empty white boxes indicate the predicted loop regions (loops 1–4).
regions between amino acids 1–5, 19–28, 58–66 and 85–102 (Fig. 2,
panel A). In addition, using the SDAP web server, these regions
did not match with any other LTPs in the database, conﬁrming the
absence of cross-reactivity between Par j 2 and other LPTs in the
database. Furthermore, using the same algorithm, three discontin-
uous epitopes were predicted (Fig. 2, panel A). The ﬁrst one was
mapped within the loop 1 region lying between helix 1 and helix
2. The remaining epitopes were mapped within the loop 3 and the
loop 4 regions covering a large number of amino acids (Fig. 2, panel
A). A 3D schematic representation of the predicted epitopes on the
target surface is shown in panel B of Fig. 2.
3.2. Cloning and expression of recombinant Par j 2 fragments
Six overlapping fragments covering the entirety of the Par j 2
sequence were generated by PCR, as schematically shown in Fig. 3.
The recombinant fragments were expressed as fusion proteins with
the E. coli Maltose-Binding Protein (MBP) to get a comparable and
efﬁcient expression of the small peptides (in particular peptides D
and F). Protein expression was  evaluated by SDS-PAGE, followed by
Coomassie brilliant blue staining showing a high level of expression
for all the fragments (Fig. 4).
3.3. Immunoblot analysis
Seventy-nine Parietaria-allergic patients were enrolled in this
study, and their individual IgE reactivity towards the six-
engineered fragments was evaluated by Western blot analysis.
Fig. 5 shows a representative analysis performed on 5 allergic
patients and one non-allergic subject (negative control). The neg-
ative control did not show any Ab binding with the whole set of
fragments (Fig. 5, panel NA). Non-recombinant MBP  protein did
not show any IgE binding in the whole set of sera studied (data not
416 V. Longo et al. / Molecular Immunology 63 (2015) 412–419
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F
wig. 4. SDS-PAGE. (A) Coomassie staining of puriﬁed recombinant MBP  (UN) and the
ix  recombinant Par j 2 derivatives (fragments A–F). M line indicates a molecular
ass marker, and numbers display the relative molecular weight.
hown). All the subjects reacted against the full-length rPar j 2 (data
ot shown). Table 1 summarizes the pattern of reactivity for the
arietaria-allergic population, showing that all the fragments were
ecognized by the IgE Abs with a heterogeneous pattern of reactiv-
ty between individuals. In particular, fragments A and B, covering
he regions from amino acid 1 to 30 and from amino acid 1 to 54,
ere recognized by the majority of the sera, with values of 80%
nd 76%, respectively. These two fragments are the only two  engi-
eered peptides capable of forming disulphide bonds resembling
he native conﬁguration. Indeed, a very high prevalence of recogni-
ion was observed for fragment C as well. Interestingly, this peptide
oes not contain any features of the native structure (i.e. formation
f disulphide bonds) suggesting the presence of dominant linear
pitope/s. Finally, patients reacted to a lower extent to fragments
–F, with percentages ranging from about 60% to 40%. Taken all
ogether, these data demonstrate that IgE reactivity was  higher
n the NH2 terminal region of the protein, but antibody binding
ig. 5. Western blot analysis of puriﬁed recombinant MBP  (UN) and the six recombinan
ith  5 Parietaria-allergic patient sera (P01-P16-P26-P28-P43) and one non-allergic contrFig. 6. Frequency distribution of the number of fragments recognized by each sub-
ject’s serum.
was detected all over the molecule, independently of the three-
dimensional structure of the protein. These data are consistent
with the in silico analysis, in which both linear and discontinuous
epitopes were predicted.
Furthermore, we  observed that the majority of the sera rec-
ognized a large number of fragments. Fig. 6 shows a histogram
indicating that more than 80% of the patients presented simulta-
neous IgE reactivity towards a number of fragments ≥3, supporting
the hypothesis that patients produce IgE versus multiple sites along
the molecule. This seems to be particularly relevant for the two
non-overlapping fragments, A and C (containing loops 1–3), which
were both recognized by 80% of all the tested sera. Although a pos-
itive trend between the intensity of the IgE binding to Par j 2 and
the number of recognized fragments has been observed, no sta-
tistical correlation has been detected (Fig. 7 p = 0.13, Kendall Rank
Correlation).
t Par j 2 derivatives (fragments A to F). The Figure shows a representative binding
ol serum (NA).
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Table  1
Individual Par j 2 and its derivatives IgE recognition.
N Par j 2 Fr. A Fr. B Fr. C Fr. D Fr. E Fr. F
1 +++ − − + − − −
2  +++ − + − − − −
3  +++ + + + + − −
4  ++++ + + + − − −
5  + − − + + − −
6  ++ − − + + + −
7  ++++ + + + + + +
8  ++ + + + − + −
9  +++ + + + + + +
10  ++ − − + + + −
11  +++ + + + − − −
12  +++ + + + + + +
13  ++++ + + + − − −
14  ++++ + + + + + −
15  +++ + + − − − −
16  ++++ − + + − − −
17  ++++ −− + − − − −
18  ++ + + − + + −
19  ++ + − + − − −
20  ++++ + + + + + −
21  ++ + + + + + −
22  +++ + − + − + +
23  ++++ − + + + + −
24  ++ − − + + − −
25  ++ + + + + + −
26  ++ + + + − − −
27  +++ + + + − − −
28  ++ + − + + + −
29  ++++ + + + + + −
30  ++ + − + + + −
31  ++ + + + + + −
32  +++ + + + − − −
33  ++++ + + − − − −
34  ++ + + + − − +
35  ++++ + + + − − −
36  ++++ + + + + + −
37  ++ + + + − + +
38  +++ + + + + + +
39  +++ − − + + − +
40  ++ + + − − − −
41  ++ + + + + + +
42  +++ + + + + + +
43  ++ + + + − − −
44  +++ − − + + + +
45  ++ − − − + + −
46  ++ − − + + + +
47  +++ + + + + + +
48  ++++ + + + + − −
49  ++ + + − + + +
50  ++ + + + − − +
51  ++++ + + + + + −
52  +++ + + + − − −
53  ++ + + − − − −
54  + + − + − + +
55  + + − − + + +
56  +++ + + + + + +
57  ++++ + + + − + +
58  + + + + + + −
59  ++ + + − + + +
60  ++++ + + + + + −
61  ++++ + + + + + +
62  ++ + + + − + −
63  ++++ + + + + + −
64  + + − + − + +
65  ++++ + + + + + +
66  + + + + + + +
67  + + + + + + +
68  + + + + + + +
69  + − − − − + +
70  +++ + − + + + +
71  + + + + + − −
72  + + + + − − −
73  ++ + + − − − +
74  ++++ + + + + + +
75  ++ + + + + + +
76  + + + + − − +
Table 1 (Continued)
N Par j 2 Fr. A Fr. B Fr. C Fr. D Fr. E Fr. F
77 ++ − − − − + −
78  ++ + + + + − −
79  + − + − + + −
Percentage of recognition 80% 76% 80% 60% 60% 40%
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Intensit y of  the  Par  j 2   signalFig. 7. Relationship between total number of recognized fragments and Par j 2
intensity. Horizontal bars indicate group medians. p = 0.13, Kendall Rank Correlation.
4. Discussion
Allergic reactions to LTPs represent a relevant clinical prob-
lem since it has been demonstrated that this widespread class of
proteins can act as life-threading allergens (Asero and Pravettoni,
2013). The experimentally determined 3D structure of several
LTPs demonstrated the presence of four -helixes separated by
short turns, and a ﬂexible and non-structured C-terminal coil
(Fig. 1) packed with four disulphide bridges, forming a large inter-
nal hydrophobic tunnel-like cavity capable of harbouring lipids
(Marion et al., 2007). However, despite such a conserved structure
and homology at the amino acid level, studies of allergen cross-
reactivity have shown that not all the components of this family
share common IgE epitopes (Lombardero et al., 2004; Tordesillas
et al., 2011). In particular, Par j 2 LTP is the most important aller-
gen involved in Parietaria allergy, with a very high prevalence of
sensitization in southern Europe (Scala et al., 2010) and no demon-
strated cross-reactivity with other LTPs (Tordesillas et al., 2011).
The investigation of the IgE/allergen interactions of the Par j 2 LTP
may  be of paramount importance for the development of vaccine
design, disease diagnosis and allergy research.
Many algorithms have been developed to predict B cell epitopes,
which are based on the characteristics of the amino acid proper-
ties together with the structural context in the molecules, such as
hydrophilicity/hydrophobicity proﬁles, ﬂexibility and accessibility
(Pomes, 2010). However, in the case of allergens, this surface under-
goes unknown modiﬁcations during the crossing of the epithelial
barrier, which make this prediction more complex (Greenbaum
et al., 2007). Furthermore, as shown for food allergens, processing
or digestion can modify the accessibility of amino acid residues and
increase the IgE binding properties of the allergen (Vissers et al.,
2011).
Using a PCR-based strategy to address this question, we
designed six overlapping regions which were expressed in E. coli
as recombinant MBP-fusion protein to allow the high and com-
parable expression of peptides of different sizes. Furthermore,
considering the heterogeneity in the immunological response and
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he polyclonality of the IgE repertoire (Gadermaier et al., 2014),
e decided to perform a study in a large set of patients (n = 79) to
ttempt to identify the domains of the protein most often involved
n IgE recognition.
The humoral response against the Par j 2 fragments conﬁrmed
he immunological relevance of the NH2 terminal region (Colombo
t al., 1998) and further highlighted the identiﬁcation of additional
pitopes in the C-terminal domain of the allergen. In particular, our
n vitro data showed that fragments A and B (containing the protein
omain surrounding the loop 1 and loop 1 + loop 2 regions, respec-
ively) were recognized by the majority of the patients (about 80%),
uggesting that these protein domains contain highly immuno-
enic regions. It is noteworthy that these two derivatives are the
nly two engineered peptides capable of forming cysteine pairing
ike that contained in the full-length wild type Par j 2. Our previ-
usly published data demonstrated that the disruption of cysteine
esidues C4, C29 and C30 dramatically reduced the IgE binding and
llergenicity of both Par j 1 and Par j 2 (Bonura et al., 2007). Taken
ogether, these data support the hypothesis that the N-terminal
egion of the allergen is highly immunogenic and that its IgE bind-
ng activity is dependent by the secondary structure of the protein.
n the other hand, the correlation between natural folding and IgE
eactivity does not seem to be essential for the C-terminal region
f Par j 2. In fact, fragments C to F do not have any cysteine residue
apable of forming native disulphide bonds yet still retain a strong
apability of binding IgE antibodies as well. This seems to be partic-
larly important for fragment C, which displays a high prevalence of
eactivity in our population (about 80% of the patients). It is impor-
ant to notice that fragments A and C express non-overlapping
egions and contain 3 out of 4 of the highly protruding surface
xposed loops (Bonura et al., 2012; Colombo et al., 1998) (loops 1
o 3) identiﬁed by the 3D modelling, revealing that both fragments
ontain immunodominant IgE epitopes.
This ﬁrst set of data can be summarized by showing that (1) all
ubjects reacted against the full-length Par j 2, showing that our
opulation is a genuinely Parietaria-allergic population (Stumvoll
t al., 2003); (2) Pj allergic patients displayed a heterogeneous pat-
ern of IgE binding to the different recombinant fragments; (3) there
as no correlation between the intensity of the signal to rPar j 2
nd the number of fragments recognized by the same serum; (4)
atients reacted simultaneously against several protein domains
pread all the over the molecule, even in fragments which do not
ontain structural features resembling the native allergen (Table 1
nd Fig. 3).
A second relevant point coming out of our study is that the
ajority of the patients reacted against a large set of fragments.
ur data show that more than 80% of the patients recognized more
han three peptides (Fig. 6). Furthermore, it could be speculated that
he disruption of the native structure of an allergen by gene frag-
entation will probably lead to the underestimation of the number
f epitopes in vivo, since this strategy identiﬁes the most relevant
pitopes and/or IgE antibodies with more afﬁnity, thus missing
pitopes which have been disrupted by the fragmentation itself,
uggesting that a larger number of the Par j 2 regions can form an
pitope. This observation raised the question of whether, despite
he low molecular weight of the Par j 2 LTP (about 10 kDa), this
llergen can be bound by several antibodies simultaneously and
hus be extremely harmful in terms of allergenic potential. In fact,
he number of IgE epitopes on an allergenic molecule (as well as the
oncentration and afﬁnity of the allergen speciﬁc antibodies) not
nly determines the extent of degranulation (Gieras et al., 2007),
ut also inﬂuences the facilitated antigen presentation-mediated T
ell activation (Holm et al., 2011) deﬁning the potency of an aller-
en. The high density IgE recognition of Par j 2 described in our
tudy is also in agreement with similar ﬁndings reported for other
ollen (Bet v 1 (Gieras et al., 2011) and Der f 2 (Lollier et al., 2014))ology 63 (2015) 412–419
and food major allergens (Bos d 5, Hev b 6 and Ara h 2) (Lollier
et al., 2011) (see (Lollier et al., 2014) for a meta-analysis), implying
that allergens can accommodate several different IgE antibodies on
small areas.
5. Conclusions
Our study provides new evidence of the presence of a large
number of IgE epitopes distributed along the protein sequence of
the major Parietaria Par j 2 allergen showing a highly immuno-
genic N-terminal region of the allergen and an unconstrained Ab
recognition in the C-terminal region of the molecule. Individual IgE
binding showed a heterogeneous pattern of recognition with a large
number of epitopic regions detected by serum antibodies. These
observations could be important for the development of new thera-
peutic options for LTP-induced mediated hypersensitivity reaction.
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